FindTrial
Sign In

Blood transfusions for preterm infants and free radicals

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN72984863
Enrollment
Unknown
Registered
2004-01-23
Start date
1998-02-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal diseases Neonatal Diseases

Interventions

Group 1 will have their need for blood transfusion monitored according to a standard protocol. Group 2 will have measurements of forearm fractional oxygen extraction (FOE) to guide their need for tran

Sponsors

NHS R&D Regional Programme Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Preterm infants

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
The primary outcome measure will be peak ODFR activity.—

Secondary

MeasureTime frame
A secondary outcome will be the number of days on the neonatal unit, retinopathy or prematurity, preventricular haemorrhage and periventricular leukomalacia and necrotising enterocolitis.—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026